National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$44.95
add to cart

Rights & Permissions

topleft topright

Responsible Research: A Systems Approach to Protecting Research Participants (2002)
Institute of Medicine (IOM)

Citation Manager

. "Appendix C: Clarifying Protocol Accountability." Responsible Research: A Systems Approach to Protecting Research Participants. Washington, DC: The National Academies Press, 2002.

Please select a format:

BibTeX EndNote RefMan


Page
258
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Responsible Research: A Systems Approach to Protecting Research Participants

HRPPP ACCOUNTABILITY TEMPLATE

Project Title: _____________________________________________________

Principal Investigator: _____________________________________________

Sponsors: ________________________________________________________

Date of Study Initiation:

________

Date of Study Completion:

_______

Official with Overall Responsibility for Human Research Participant

Protection Program: _______________________________________________

Risk Assessment:

❏ Minimal

❏ More than Minimal

For each category listed below, please write the name of the individual or body (e.g., Research ERB) responsible for overseeing the task. Please circle either Yes or No (Y or N) where appropriate to indicate if the item is applicable.

PROTOCOL DEVELOPMENT

Applicable? If yes, please identify responsible party.

1.

Research Design:

___________________

2.

If drug, biological agent, or device is administered:

 

Is the dose/route/indication FDA approved?

Y / N

 

If not, is there an IND, IDE?

Y / N

 

Who is the holder of the IND, IDE?

___________________

 

Who is the responsible party for the following:

 

Manufacturing product following GMP?

___________________

 

Ensuring availability of adequate supply of product to conduct trial?

___________________

 

Packaging, labeling, and distribution?

___________________

 

Storage, usage, disposal, and accountability at clinical sites following GCP?

___________________

3. For procedures conducted during the study (e.g., cardiac catheterization, psychological profile), who is responsible for ensuring that:

 

Procedures are standardized, well established, and clearly defined?

___________________

 

Individuals conducting procedure(s) are properly credentialed and/or trained?

___________________

Page
258